Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Jan;35(1):117–121. doi: 10.1136/gut.35.1.117

Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.

M Boscaini 1, M Piccinni-Leopardi 1, F Andreotti 1, A Montori 1
PMCID: PMC1374645  PMID: 8307431

Abstract

Between November 1988 and July 1992 70 patients with radiolucent gall stones were treated with extracorporeal lithotripsy (ESL) and ursodeoxycholic acid (UDCA; mean (SD) dose 11.2 (1.9) mg/kg/day). Fifty three patients have been followed for one year. One week after lithotripsy, 30.6% had completely eliminated all stone fragments from the gall bladder and one year later 93.9% were free of stones. Three factors were considered important in achieving these results. 'Pulverisation' of the stone--that is, its fragmentation into echogenic dust (crystalline aggregates, some few hundred mu in size) or particles similar to grains of sand, smaller than 1 mm in diameter, or both, is required. Secondly, dust and particles were rapidly eliminated, strongly suggesting a mechanical elimination process by physiological gall bladder contractions. Thirdly, there must be chemical dissolution with biliary acids. This therapeutic approach gave excellent results without causing any clinically relevant side effects. The first 20 patients who became free of stones after ESL were given oral bile acid maintenance treatment--300 mg/day of UDCA at bedtime, for two years. All were asymptomatic and none had suffered a recurrence after two years. In four patients, crystalline aggregates, detected in gall bladder bile by ultrasound, were subsequently dissolved between one and three months after resuming a full dose regimen of UDCA.

Full text

PDF
117

Images in this article

119Figure 2
on p.119
121Figure 3
on p.121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boscaini M., Magnani G., Mandetta S., Montori A. Morphological appearance of low-level echoes in the gallbladder. Interpretation with microscopic biliary analysis and clinical correlation. Surg Endosc. 1987;1(1):41–49. doi: 10.1007/BF00703087. [DOI] [PubMed] [Google Scholar]
  2. Burnett D., Ertan A., Jones R., O'Leary J. P., Mackie R., Robinson J. E., Jr, Salen G., Stahlgren L., Van Thiel D. H., Vassy L. Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study. Dig Dis Sci. 1989 Jul;34(7):1011–1015. doi: 10.1007/BF01536365. [DOI] [PubMed] [Google Scholar]
  3. Greiner L., Münks C., Heil W., Jakobeit C. Gallbladder stone fragments in feces after biliary extracorporeal shock-wave lithotripsy. Gastroenterology. 1990 Jun;98(6):1620–1624. doi: 10.1016/0016-5085(90)91099-r. [DOI] [PubMed] [Google Scholar]
  4. Lanzini A., Jazrawi R. P., Kupfer R. M., Maudgal D. P., Joseph A. E., Northfield T. C. Gallstone recurrence after medical dissolution. An overestimated threat? J Hepatol. 1986;3(2):241–246. doi: 10.1016/s0168-8278(86)80033-2. [DOI] [PubMed] [Google Scholar]
  5. Marks J. W., Lan S. P., Baum R. A., Habig R. L., Hanson R. F., Hersh T., Hightower N. C., Jr, Hofmann A. F., Lachin J. M., Lasser E. C. Low-dose chenodiol to prevent gallstone recurrence after dissolution therapy. Ann Intern Med. 1984 Mar;100(3):376–381. doi: 10.7326/0003-4819-100-3-376. [DOI] [PubMed] [Google Scholar]
  6. O'Donnell L. D., Heaton K. W. Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up. Gut. 1988 May;29(5):655–658. doi: 10.1136/gut.29.5.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ruppin D. C., Dowling R. H. Is recurrence inevitable after gallstone dissolution by bile-acid treatment? Lancet. 1982 Jan 23;1(8265):181–185. doi: 10.1016/s0140-6736(82)90757-7. [DOI] [PubMed] [Google Scholar]
  8. Sackmann M., Pauletzki J., Sauerbruch T., Holl J., Schelling G., Paumgartner G. The Munich Gallbladder Lithotripsy Study. Results of the first 5 years with 711 patients. Ann Intern Med. 1991 Feb 15;114(4):290–296. doi: 10.7326/0003-4819-114-4-290. [DOI] [PubMed] [Google Scholar]
  9. Salen G. Gallstone dissolution therapy with ursodiol. Efficacy and safety. Dig Dis Sci. 1989 Dec;34(12 Suppl):39S–43S. doi: 10.1007/BF01536661. [DOI] [PubMed] [Google Scholar]
  10. Schoenfield L. J., Berci G., Carnovale R. L., Casarella W., Caslowitz P., Chumley D., Davis R. C., Gillenwater J. Y., Johnson A. C., Jones R. S. The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones. The Dornier National Biliary Lithotripsy Study. N Engl J Med. 1990 Nov 1;323(18):1239–1245. doi: 10.1056/NEJM199011013231804. [DOI] [PubMed] [Google Scholar]
  11. Shapiro R. S., Winsberg F. Comet-tail artifact from cholesterol crystals: observations in the postlithotripsy gallbladder and an in vitro model. Radiology. 1990 Oct;177(1):153–156. doi: 10.1148/radiology.177.1.2204960. [DOI] [PubMed] [Google Scholar]
  12. Toulet J., Rousselet J., Viteau J. M., Duchon Y., Pagniez R., Samain B., Vienne J. L. Récidives et prévention des récidives après dissolution de la lithiase vésiculaire par l'acide chénodésoxycholique chez 22 patients. Gastroenterol Clin Biol. 1983 Jun-Jul;7(6-7):605–609. [PubMed] [Google Scholar]
  13. Villanova N., Bazzoli F., Taroni F., Frabboni R., Mazzella G., Festi D., Barbara L., Roda E. Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology. 1989 Sep;97(3):726–731. doi: 10.1016/0016-5085(89)90644-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES